RxDoctor Payments Data

Timothy Blanchet, DO

Family Medicine · Washington, MINPI 1053355172

Payments from drug & device makers

$2,015in general payments, 2019–2025

Across 128 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$402
  • Pfizer$217
  • Lilly USA, LLC$174
  • AstraZeneca$164
  • Amgen$113
  • Exact Sciences$105
  • plus $839 from 24 others

What the payments were for

  • Food & beverage$2,015100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,015 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$60,113
Medicare patients
194
Services billed
5,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide67$73,655
JanuviaSitagliptin Phosphate59$67,813
EliquisApixaban29$46,367
JardianceEmpagliflozin31$42,218
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$32,817
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$11,348
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$9,025
ShingrixVaricella-Zoster Ge/As01b/Pf43$8,854
Atorvastatin Calcium403$5,548
Rosuvastatin Calcium243$4,718
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,968
Levothyroxine Sodium297$3,723
Metoprolol Succinate170$3,373
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate17$3,041
Losartan Potassium182$2,462

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$402$73,65567 claims
MerckJanuvia$62$67,81359 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix$48$50,69689 claims
PfizerEliquis$217$46,36729 claims
Boehringer IngelheimJardiance$54$42,21831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Washington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →